Longevity Protocol
A daily drink-mix-and-capsule protocol designed around meaningful ingredient doses, deliberate delivery choices, and the science of healthy aging.
Formula in development. Displayed quantities are proposed daily active-dose targets, not finalized Supplement Facts or verified finished-product claims.
Built for the long game.
Beyond the next workout: a considered daily formula organized around four areas of long-term health.
Support the systems that turn nutrients into cellular energy and help maintain muscle function.
NMN · Urolithin A · CoQ10 · PQQEXPLORE THE INGREDIENTS ↗Support healthy cholesterol management and the normal biological systems involved in circulation and vascular health.
Plant Sterols · Vitamin K2EXPLORE THE INGREDIENTS ↗Focus on the body’s antioxidant-response systems and everyday oxidative stress.
Sulforaphane · Ergothioneine · Astaxanthin · TocotrienolsEXPLORE THE INGREDIENTS ↗Support normal metabolic maintenance and foundational bone health over time.
Ca-AKG · Spermidine · Vitamin D3EXPLORE THE INGREDIENTS ↗These are formulation aims and ingredient-level areas of study—not demonstrated outcomes of the finished Protect protocol.
Understand what each ingredient is intended to do, the amount selected for Protect, and how closely published human research matches that dose.
NO PROPRIETARY BLENDS. NO UNCHECKED PROMISES.Supports the cellular NAD+ pathway, which is involved in energy metabolism.
An 80-person trial studied 300, 600, and 900 mg daily for 60 days and found increased blood NAD+ levels. The proposed 500 mg dose falls within that studied range, but was not a separate treatment arm. Raising NAD+ has not been shown to extend human lifespan.
Comparable doses studiedInvestigated for mitochondrial renewal and its possible connection to maintaining muscle function with age.
In an 88-person, four-month randomized study, 500 mg/day improved certain leg-strength measures versus placebo. Peak power, the primary endpoint, was not significantly improved; larger trials are needed.
Exact dose studiedA naturally occurring cofactor in the cellular machinery that converts nutrients into usable energy.
A randomized trial used 200 mg/day in patients with congestive heart failure; blood CoQ10 rose, but exercise capacity and cardiac function did not improve in that trial. Effects in healthy adults cannot be inferred.
Exact dose studiedA compound being studied for cognitive function and cell signaling related to mitochondrial health.
A 12-week placebo-controlled study used 20 mg/day and reported improvements in some memory and cognitive test results. The study was relatively small and does not establish broad or long-term brain-health benefits.
Exact dose studiedHelp limit cholesterol absorption in the digestive tract, supporting healthy LDL cholesterol levels.
Evidence reviews found average LDL reductions around 7–10.5% with 1.5–2.4 g/day in studied food formats. Results cannot be assumed to transfer directly to Protect’s proposed water-dispersible powder.
Dose range studiedContributes to normal blood clotting and is being studied for its role in calcium-related proteins.
A three-year trial in 244 postmenopausal women used 180 µg/day and reported improvement in selected arterial-stiffness measures. This does not establish cardiovascular risk reduction in healthy adults generally.
Exact dose studiedStudied for its influence on the body’s own cellular antioxidant-response pathways.
In a small crossover study of 10 young men, 30 mg/day for four weeks changed some exercise-related muscle-damage and inflammatory markers. This does not prove long-term protection. Protect targets ready-formed sulforaphane rather than relying on precursor conversion; final potency is pending verification.
Exact dose studiedA naturally occurring antioxidant amino acid being investigated for cellular protection.
A small 12-week trial tested mushroom tablets supplying 25 mg/day and found changes in selected skin-moisture outcomes. Because this was a mushroom-based intervention, it does not prove equivalent effects from isolated ergothioneine in Protect.
Related formula studiedA carotenoid antioxidant being studied for its potential to help manage oxidative stress.
An eight-week trial tested 2 mg and 8 mg daily in healthy women and found changes in some oxidative-stress and immune markers, but not all outcomes improved. It does not establish a broad protective effect.
Exact dose studiedMembers of the vitamin E family being investigated for antioxidant and bone-related effects.
A 12-week randomized study of annatto tocotrienols used approximately 300 or 600 mg/day of active tocotrienols in postmenopausal women. The proposed 200 mg active dose is lower; its clinical effect cannot be assumed from that trial.
Higher doses studiedProvides alpha-ketoglutarate, a molecule involved in the body’s energy-producing metabolic cycle.
A controlled study of 1 g/day sustained-release Ca-AKG in 120 adults has published recruitment findings, but those do not establish a longevity, biological-age, or functional benefit. Protect’s formula is not identical to the trial preparation.
Human efficacy pendingA natural cellular compound under investigation for roles in cellular maintenance and autophagy.
A 2026 pilot randomized study in 40 older adults used 6 mg/day for 13 weeks and reported selected immune-response findings. It is too small and population-specific to establish general longevity benefits. An earlier larger trial at 0.9 mg/day found no primary memory benefit.
Exact dose studied — earlyHelps the body absorb calcium and maintain normal bone and muscle function.
NIH identifies 600 IU/day as the recommended intake for most adults aged 19–70, and 800 IU/day after 70. The proposed 1,000 IU is above those recommendations; added benefit depends on nutritional status and individual needs.
Established nutrient roleThe proposed daily doses below are formulation targets, not final Supplement Facts declarations.
A delicious pomegranate-flavored drink mix designed to accommodate larger-dose actives and specialized dry delivery forms—with no artificial flavors or coloring.
A complementary capsule format designed for selected actives, including ingredients that call for particular attention to stability and potency.
Suggested use concept: mix and drink one serving daily, and take two capsules alongside a meal containing fat. Final directions remain subject to formulation and label review.
CoQ10 and tocotrienols: solid self-emulsifying or equivalent optimized dry delivery is specified, pending manufacturer validation. Sulforaphane: 30 mg of actual preformed active, not theoretical precursor yield. Tocotrienols and other amounts are active-dose targets; PQQ and spermidine require confirmation of the assay and chemical basis.
*Plant Sterols: 2,000 mg/day preferred, with 1,500 mg/day as the minimum fallback if required for feasibility. All displayed amounts are proposed active-dose targets, pending final formulation, assays, manufacturing review and labeling approval.
Amount is only part of the equation. Protect is designed with attention to each ingredient’s stability, compatibility, and delivery—not simply the number printed on a label.
Solid self-emulsifying systems or comparable optimized dry forms are specified for fat-soluble CoQ10 and annatto tocotrienols to address their delivery challenges.
Selected actives—including preformed sulforaphane and astaxanthin—call for stabilized forms and appropriate processing, packaging, and potency verification.
Powder and capsules each serve a role. Ingredient placement is designed around practical dose capacity, compatibility, and stability—not convenience alone.
These are requested manufacturing specifications. Heiner must still confirm the delivery technologies, fill feasibility, potency and stability. We do not claim superior human absorption without direct evidence.
The proposed 30-day routine pairs one serving of the drink mix with two hard capsules daily, ideally alongside a meal containing fat. Exact mixing directions, timing, and precautions will be finalized after formulation and labeling review.
Daily amounts specify targeted active content, not merely raw extract weight. Final assays and finished-product labeling are pending.
Ingredient form and placement are specified intentionally, with manufacturing suitability to be confirmed.
Final ingredient specifications, potency assays, quality testing, and label claims require verification before launch.
The proposed 30-day set pairs a delicious pomegranate-flavored drink mix with two hard capsules daily. Together, the two formats contain 13 targeted ingredients.
The drink mix accommodates larger-dose actives and selected dry delivery systems, while the capsules hold complementary ingredients. Placement is chosen with dose, compatibility, and stability in mind and remains subject to manufacturer verification.
Some ingredients are difficult to deliver or maintain in their active form. Protect specifies specialized dry-delivery options for selected ingredients, including CoQ10 and tocotrienols. Any claimed improvement in absorption will require supporting data.
These are the latest proposed active-dose targets, not approved Supplement Facts. Manufacturing feasibility, potency verification, regulatory review, and final labeling remain pending.
The current concept is one serving of the drink mix plus two capsules once daily, ideally alongside a meal containing fat. Follow the final product label once available, and consult a healthcare professional before use—particularly if you take medication, including blood thinners. Vitamin K2 can interact with warfarin.